Sinopharm Group Forecast, price target & analysts
HK$15.65
0.32%
Hong Kong, Oct 15, 04:08 pm HKT.
Closed.
Industry
Sinopharm Group Target price 2026 - Analyst rating & recommendation
Powered by
Sinopharm Group Classifications & Recommendation
Buy
71%
Hold
29%
Sinopharm Group Price Target
| Target Price | HK$21.22 |
| Price | HK$15.65 |
| Potential | |
| Number of Estimates | 17 |
| 17 Analysts have issued a price target Sinopharm Group 2027 . The average Sinopharm Group target price is HK$21.22. This is higher than the current stock price. The highest price target is , the lowest is . | |
| A rating was issued by 21 analysts: 15 Analysts recommend Sinopharm Group to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Sinopharm Group stock has an average upside potential 2027 of . Most analysts recommend the Sinopharm Group stock at Purchase. |
Sales and Margin forecast 2026, 2027 & 2028
Create a premium account to unlock analyst estimates.
Learn more
Powered by
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion HK$ | ??? | ??? |
| ??? | ??? | |
| EBITDA Margin | ??? | ??? |
| ??? | ??? | |
| Net Margin | ??? | ??? |
| ??? | ??? |
16 Analysts have issued a sales forecast Sinopharm Group 2026 . The average Sinopharm Group sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
17 Sinopharm Group Analysts have issued a net profit forecast 2026. The average Sinopharm Group net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
Create a premium account to unlock analyst estimates.
Learn more
Powered by
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share HK$ | ??? | ??? |
| ??? | ??? | |
| P/E | ??? | |
| EV/Sales | ??? |
Sinopharm Group...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
